Several pieces of research have suggested the potential growth-suppressor and anti-tumorigenesis properties of PTPRO, notably in hepatocellular carcinoma [18, 41], breast cancer [9, 42, 43] and colorectal tumor [44]. Here, PTPRO is linked to hepatocellular carcinoma.